Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-046664
Filing Date
2026-02-11
Accepted
2026-02-11 16:30:04
Documents
1
Period of Report
2026-02-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 18967
  Complete submission text file 0001193125-26-046664.txt   20645
Mailing Address 104 5TH AVENUE 19TH FLOOR NEW YORK NY 10011
Business Address
Mathers Edward T (Reporting) CIK: 0001328625 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-43105 | Film No.: 26621216

Mailing Address 27081 ALISO CREEK ROAD SUITE 125 ALISO VIEJO CA 92656
Business Address 27081 ALISO CREEK ROAD SUITE 125 ALISO VIEJO CA 92656 949-284-6904
SpyGlass Pharma, Inc. (Issuer) CIK: 0001778922 (see all company filings)

EIN.: 833044245 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)